Hepatitis C success based on strong research
[PRESS INVITATION, 18 May 2015] The new hepatitis C drugs represent a genuine breakthrough in pharmaceutical research, and would not have been possible without the work done on the virus by Charles Rice at Rockefeller University. Dr Rice is now coming to Sweden to speak about hepatitis C for the annual Nicholson lecture, where an introduction will be given by one of Sweden’s best-known hepatitis C patients, Professor Hans Rosling.Reporters are welcome to attend the lecture and interview the speakers.Nicholson Lecture: Hepatitis C: 26 Years LaterSpeakers: Dr. Charles M. Rice, professor